SCHEMBL25696296

SCHEMBL25696296

COC1OC(C)(C(=O)O)C(O)C(O)C1O

nearest known ligand 0.34

Predicted protein targets (top 2)

geneUniProtsupporting neighboursconfidence
▸ IDUA P35475 1/20 0.34
▸ SLC5A2 P31639 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL21386691 1.00 IDUA (0.34) IDUASLC5A2
SCHEMBL13134062 0.76 IDUA (0.38) IDUA
SCHEMBL13134061 0.76 IDUA (0.38) IDUA
SCHEMBL17256226 0.76 IDUA (0.38) IDUA
SCHEMBL25693456 0.75 IDUA (0.37) IDUA
SCHEMBL18819594 0.72 IDUA (0.34) IDUA
SCHEMBL23358401 0.70 PYGB (0.44) —
SCHEMBL18820165 0.70 PYGB (0.44) —
SCHEMBL12764243 0.68 PYGB (0.39) —
SCHEMBL12332696 0.68 MGAM (0.40) SLC5A2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2023122494-A1 COMPOSITIONS AND METHODS OF USE TO TREAT 12-LIPOXYGENASE (12-LOX) MEDIATED DISEASES VERALOX THERAPEUTICS (US) 2023-06-29 — — WO disclosed
Send feedback